Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats

Hiroyuki Tsutsui, Yuji Ishibashi, Masaru Takahashi, Takashi Namba, Hirofumi Tagawa, Kyoko Imanaka-Yoshida, Akira Takeshita

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

To determine whether the long-term inhibition of microtubule integrity in vitro by colchicine could attenuate the development of cardiac hypertrophy, we studied five groups of rats: Wistar-Kyoto rats receiving saline for 4 weeks (WKY saline); WKY receiving colchicine, which depolymerizes microtubules (WKY colchicine); spontaneously hypertensive rats receiving saline (SHR saline); SHRs receiving colchicine (SWR colchicine); and SHRs receiving lumicolchicine, an inactive stereoisomer of colchicine (SHK lumicolchicine). Seven-week-old animals were administered drugs or control substances via alternate day intraperitoneal injection for a period of 4 weeks. Dosage was gradually increased from 0.6 to 1.0 mg/kg to avoid drug toxicity. Depolymerization of myocardial microtubules by the in vivo administration of colchicine into the rats was confirmed by both Western blot analysis and immunofluorescence of tubulin protein in the hearts. Body weight (BW) was lower, while systolic blood pressure was significantly elevated in SHRs vs the WKY rats. No significant difference was found in either of these parameters between the control or treatment groups of each strain. Left ventricular (LV) weight-to-BW ratio was elevated and showed significant increases in the SHRs as compared to WKY animals, indicative of cardiac hypertrophy. When the SHRs were treated with colchicine but not vehicle or lumicolchicine, LV/BW was similar to the WKY. Changes of myocyte cross-sectional area determined using LV mid-free wall specimens were concordant with the LV/BW data. No significant changes were found in collagen volume fraction between groups. Thus the inhibition of microtubule polymerization abolished the progression of cardiac myocyte hypertrophy in SHRs independently of blood pressure.

Original languageEnglish
Pages (from-to)1203-1213
Number of pages11
JournalJournal of Molecular and Cellular Cardiology
Volume31
Issue number6
DOIs
Publication statusPublished - Jan 1 1999

Fingerprint

Colchicine
Cardiomegaly
Inbred SHR Rats
Microtubules
Body Weight
Inbred WKY Rats
Blood Pressure
Stereoisomerism
Drug and Narcotic Control
Tubulin
Intraperitoneal Injections
Drug-Related Side Effects and Adverse Reactions
Cardiac Myocytes
Polymerization
Muscle Cells
Fluorescent Antibody Technique
Collagen
Western Blotting
Weights and Measures

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. / Tsutsui, Hiroyuki; Ishibashi, Yuji; Takahashi, Masaru; Namba, Takashi; Tagawa, Hirofumi; Imanaka-Yoshida, Kyoko; Takeshita, Akira.

In: Journal of Molecular and Cellular Cardiology, Vol. 31, No. 6, 01.01.1999, p. 1203-1213.

Research output: Contribution to journalArticle

Tsutsui, H, Ishibashi, Y, Takahashi, M, Namba, T, Tagawa, H, Imanaka-Yoshida, K & Takeshita, A 1999, 'Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats', Journal of Molecular and Cellular Cardiology, vol. 31, no. 6, pp. 1203-1213. https://doi.org/10.1006/jmcc.1999.0953
Tsutsui, Hiroyuki ; Ishibashi, Yuji ; Takahashi, Masaru ; Namba, Takashi ; Tagawa, Hirofumi ; Imanaka-Yoshida, Kyoko ; Takeshita, Akira. / Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats. In: Journal of Molecular and Cellular Cardiology. 1999 ; Vol. 31, No. 6. pp. 1203-1213.
@article{21dacb2648df4c128ffb42b07f56b388,
title = "Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats",
abstract = "To determine whether the long-term inhibition of microtubule integrity in vitro by colchicine could attenuate the development of cardiac hypertrophy, we studied five groups of rats: Wistar-Kyoto rats receiving saline for 4 weeks (WKY saline); WKY receiving colchicine, which depolymerizes microtubules (WKY colchicine); spontaneously hypertensive rats receiving saline (SHR saline); SHRs receiving colchicine (SWR colchicine); and SHRs receiving lumicolchicine, an inactive stereoisomer of colchicine (SHK lumicolchicine). Seven-week-old animals were administered drugs or control substances via alternate day intraperitoneal injection for a period of 4 weeks. Dosage was gradually increased from 0.6 to 1.0 mg/kg to avoid drug toxicity. Depolymerization of myocardial microtubules by the in vivo administration of colchicine into the rats was confirmed by both Western blot analysis and immunofluorescence of tubulin protein in the hearts. Body weight (BW) was lower, while systolic blood pressure was significantly elevated in SHRs vs the WKY rats. No significant difference was found in either of these parameters between the control or treatment groups of each strain. Left ventricular (LV) weight-to-BW ratio was elevated and showed significant increases in the SHRs as compared to WKY animals, indicative of cardiac hypertrophy. When the SHRs were treated with colchicine but not vehicle or lumicolchicine, LV/BW was similar to the WKY. Changes of myocyte cross-sectional area determined using LV mid-free wall specimens were concordant with the LV/BW data. No significant changes were found in collagen volume fraction between groups. Thus the inhibition of microtubule polymerization abolished the progression of cardiac myocyte hypertrophy in SHRs independently of blood pressure.",
author = "Hiroyuki Tsutsui and Yuji Ishibashi and Masaru Takahashi and Takashi Namba and Hirofumi Tagawa and Kyoko Imanaka-Yoshida and Akira Takeshita",
year = "1999",
month = "1",
day = "1",
doi = "10.1006/jmcc.1999.0953",
language = "English",
volume = "31",
pages = "1203--1213",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "6",

}

TY - JOUR

T1 - Chronic colchicine administration attenuates cardiac hypertrophy in spontaneously hypertensive rats

AU - Tsutsui, Hiroyuki

AU - Ishibashi, Yuji

AU - Takahashi, Masaru

AU - Namba, Takashi

AU - Tagawa, Hirofumi

AU - Imanaka-Yoshida, Kyoko

AU - Takeshita, Akira

PY - 1999/1/1

Y1 - 1999/1/1

N2 - To determine whether the long-term inhibition of microtubule integrity in vitro by colchicine could attenuate the development of cardiac hypertrophy, we studied five groups of rats: Wistar-Kyoto rats receiving saline for 4 weeks (WKY saline); WKY receiving colchicine, which depolymerizes microtubules (WKY colchicine); spontaneously hypertensive rats receiving saline (SHR saline); SHRs receiving colchicine (SWR colchicine); and SHRs receiving lumicolchicine, an inactive stereoisomer of colchicine (SHK lumicolchicine). Seven-week-old animals were administered drugs or control substances via alternate day intraperitoneal injection for a period of 4 weeks. Dosage was gradually increased from 0.6 to 1.0 mg/kg to avoid drug toxicity. Depolymerization of myocardial microtubules by the in vivo administration of colchicine into the rats was confirmed by both Western blot analysis and immunofluorescence of tubulin protein in the hearts. Body weight (BW) was lower, while systolic blood pressure was significantly elevated in SHRs vs the WKY rats. No significant difference was found in either of these parameters between the control or treatment groups of each strain. Left ventricular (LV) weight-to-BW ratio was elevated and showed significant increases in the SHRs as compared to WKY animals, indicative of cardiac hypertrophy. When the SHRs were treated with colchicine but not vehicle or lumicolchicine, LV/BW was similar to the WKY. Changes of myocyte cross-sectional area determined using LV mid-free wall specimens were concordant with the LV/BW data. No significant changes were found in collagen volume fraction between groups. Thus the inhibition of microtubule polymerization abolished the progression of cardiac myocyte hypertrophy in SHRs independently of blood pressure.

AB - To determine whether the long-term inhibition of microtubule integrity in vitro by colchicine could attenuate the development of cardiac hypertrophy, we studied five groups of rats: Wistar-Kyoto rats receiving saline for 4 weeks (WKY saline); WKY receiving colchicine, which depolymerizes microtubules (WKY colchicine); spontaneously hypertensive rats receiving saline (SHR saline); SHRs receiving colchicine (SWR colchicine); and SHRs receiving lumicolchicine, an inactive stereoisomer of colchicine (SHK lumicolchicine). Seven-week-old animals were administered drugs or control substances via alternate day intraperitoneal injection for a period of 4 weeks. Dosage was gradually increased from 0.6 to 1.0 mg/kg to avoid drug toxicity. Depolymerization of myocardial microtubules by the in vivo administration of colchicine into the rats was confirmed by both Western blot analysis and immunofluorescence of tubulin protein in the hearts. Body weight (BW) was lower, while systolic blood pressure was significantly elevated in SHRs vs the WKY rats. No significant difference was found in either of these parameters between the control or treatment groups of each strain. Left ventricular (LV) weight-to-BW ratio was elevated and showed significant increases in the SHRs as compared to WKY animals, indicative of cardiac hypertrophy. When the SHRs were treated with colchicine but not vehicle or lumicolchicine, LV/BW was similar to the WKY. Changes of myocyte cross-sectional area determined using LV mid-free wall specimens were concordant with the LV/BW data. No significant changes were found in collagen volume fraction between groups. Thus the inhibition of microtubule polymerization abolished the progression of cardiac myocyte hypertrophy in SHRs independently of blood pressure.

UR - http://www.scopus.com/inward/record.url?scp=0033153246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033153246&partnerID=8YFLogxK

U2 - 10.1006/jmcc.1999.0953

DO - 10.1006/jmcc.1999.0953

M3 - Article

C2 - 10371695

AN - SCOPUS:0033153246

VL - 31

SP - 1203

EP - 1213

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 6

ER -